Isatuximab plus carfilzomib–dexamethasone versus carfilzomib–dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial
| Autor: | Yong, Kwee *, Martin, Thomas, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Špička, Ivan, Baker, Ross, Kim, Kihyun, Martinez, Gracia, Min, Chang-Ki, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Koh, Youngil, Suzuki, Kenshi, Casca, France, Macé, Sandrine, Risse, Marie-Laure, Moreau, Philippe |
|---|---|
| Zdroj: | In The Lancet Haematology October 2024 11(10):e741-e750 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|